Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion. The deal covers DS-1062, Daiichi Sankyo’s proprietary antibody-drug ...
01/15/2025 Application (24A706) to extend the time to file a petition for a writ of certiorari from February 4, 2025 to March 6, 2025, submitted to Justice Alito. 01/17/2025 Response to application ...
This mysql-async Library for FiveM intends to provide function to connect to a MySQL in a Sync and Async way. This resource is inspired by fivem-mysql-async and written by ThymonA ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback